1h Free Analyst Time
The publisher has been monitoring the gout therapeutics market and it is poised to grow by $2.69 bn during 2021-2025, progressing at a CAGR of over 14% during the forecast period. The report on gout therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by technological advancements in medical imaging and the popularity of off-label and OTC drugs.
The gout therapeutics market analysis includes the drug class segment and geographic landscape.
The gout therapeutics market is segmented as below:
By Drug Class
- NSAIDs
- Urate-lowering agents
- Corticosteroids
- Colchicine
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the increasing number of clinical trials for gout therapeutics as one of the prime reasons driving the gout therapeutics market growth during the next few years.
The report on gout therapeutics market covers the following areas:
- Gout therapeutics market sizing
- Gout therapeutics market forecast
- Gout therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gout therapeutics market vendors that include AstraZeneca Plc, Avion Pharmaceuticals LLC, Cadila Healthcare Ltd., Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Ironwood Pharmaceuticals Inc., JW Pharmaceutical Corp., Selecta Biosciences Inc., Takeda Pharmaceutical Co. Ltd., and Teijin Ltd. Also, the gout therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Drug class
- Market segments
- Comparison by Drug class
- NSAIDs - Market size and forecast 2020-2025
- Urate-lowering agents - Market size and forecast 2020-2025
- Corticosteroids - Market size and forecast 2020-2025
- Colchicine - Market size and forecast 2020-2025
- Market opportunity by Drug class
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AstraZeneca Plc
- Avion Pharmaceuticals LLC
- Cadila Healthcare Ltd.
- Hikma Pharmaceuticals Plc
- Horizon Therapeutics Plc
- Ironwood Pharmaceuticals Inc.
- JW Pharmaceutical Corp.
- Selecta Biosciences Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teijin Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Drug class - Market share 2020-2025 (%)
- Comparison by Drug class
- NSAIDs - Market size and forecast 2020-2025 ($ million)
- NSAIDs - Year-over-year growth 2020-2025 (%)
- Urate-lowering agents - Market size and forecast 2020-2025 ($ million)
- Urate-lowering agents - Year-over-year growth 2020-2025 (%)
- Corticosteroids - Market size and forecast 2020-2025 ($ million)
- Corticosteroids - Year-over-year growth 2020-2025 (%)
- Colchicine - Market size and forecast 2020-2025 ($ million)
- Colchicine - Year-over-year growth 2020-2025 (%)
- Market opportunity by Drug class
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product and service
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Key customers
- AstraZeneca Plc - Segment focus
- Avion Pharmaceuticals LLC - Overview
- Avion Pharmaceuticals LLC - Product and service
- Avion Pharmaceuticals LLC - Key offerings
- Avion Pharmaceuticals LLC - Key customers
- Avion Pharmaceuticals LLC - Segment focus
- Cadila Healthcare Ltd. - Overview
- Cadila Healthcare Ltd. - Business segments
- Cadila Healthcare Ltd. - Key offerings
- Cadila Healthcare Ltd. - Key customers
- Cadila Healthcare Ltd. - Segment focus
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Key customers
- Hikma Pharmaceuticals Plc - Segment focus
- Horizon Therapeutics Plc - Overview
- Horizon Therapeutics Plc - Business segments
- Horizon Therapeutics Plc - Key offerings
- Horizon Therapeutics Plc - Key customers
- Horizon Therapeutics Plc - Segment focus
- Ironwood Pharmaceuticals Inc. - Overview
- Ironwood Pharmaceuticals Inc. - Business segments
- Ironwood Pharmaceuticals Inc. - Key offerings
- Ironwood Pharmaceuticals Inc. - Key customers
- Ironwood Pharmaceuticals Inc. - Segment focus
- JW Pharmaceutical Corp. - Overview
- JW Pharmaceutical Corp. - Product and service
- JW Pharmaceutical Corp. - Key offerings
- JW Pharmaceutical Corp. - Key customers
- JW Pharmaceutical Corp. - Segment focus
- Selecta Biosciences Inc. - Overview
- Selecta Biosciences Inc. - Product and service
- Selecta Biosciences Inc. - Key offerings
- Selecta Biosciences Inc. - Key customers
- Selecta Biosciences Inc. - Segment focus
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product and service
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- Takeda Pharmaceutical Co. Ltd. - Key customers
- Takeda Pharmaceutical Co. Ltd. - Segment focus
- Teijin Ltd. - Overview
- Teijin Ltd. - Business segments
- Teijin Ltd. - Key offerings
- Teijin Ltd. - Key customers
- Teijin Ltd. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global gout therapeutics market: AstraZeneca Plc, Avion Pharmaceuticals LLC, Cadila Healthcare Ltd., Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Ironwood Pharmaceuticals Inc., JW Pharmaceutical Corp., Selecta Biosciences Inc., Takeda Pharmaceutical Co. Ltd., and Teijin Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing number of clinical trials for gout therapeutics.`
According to the report, one of the major drivers for this market is the technological advancements in medical imaging.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Avion Pharmaceuticals LLC
- Cadila Healthcare Ltd.
- Hikma Pharmaceuticals Plc
- Horizon Therapeutics Plc
- Ironwood Pharmaceuticals Inc.
- JW Pharmaceutical Corp.
- Selecta Biosciences Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teijin Ltd.
